The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 601–700 of 1,810
Milan, K. L., Gayatri, V., Kumaran, K., Nagarajan, S., Palanivel, S. V., Anuradha, M., & Ramkumar, K. M. (2024) · Placenta · doi:10.1016/j.placenta.2024.10.021 · Cited by 9
Correlation of Insulin Resistance in Pregnancy with Obstetric Outcome
Bano, S., Agrawal, A., Asnani, M., Das, V., Singh, R., Pandey, A., Kumar, N., & Ali, W. (2021) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-021-01426-9 · Cited by 11
Mathew, A. P., Cutshaw, G., Appel, O., Funk, M. L., Synan, L., Waite, J. R., Ghazvini, S., Wen, X., Sarkar, S., Santillan, M. K., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10691 · Cited by 12
Cao, Y.-M., Wang, W., Cai, N.-N., Ma, M., Liu, J., Zhang, P., Xue, L., & Liu, Y.-Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s316878 · Cited by 10
“The development of GDM is related to the impaired glucose tolerance caused by the dysfunction of maternal pancreatic β-cells.(23) Glucose passes through the placenta to the fetus and causes increased fetal insulin secretion, stimulating fetal growth, resulting in macrosomia and Older than gestational age (LGA).”
BackgroundThe Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review
Sadowska, A., Poniedziałek‐Czajkowska, E., & Mierzyński, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417298 · Cited by 12
Yu, H., Sun, J., & Hu, H. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03380-z · Cited by 13
Ondřejíková, L., Pařízek, A., Šimják, P., Vejražková, D., Velíková, M., Anderlová, K., Vosátková, M., Krejčí, H., Koucký, M., Kancheva, R. L., et al. (2021) · Biomolecules · doi:10.3390/biom11121746 · Cited by 12
“A number of interrelated factors (including steroids) affecting both insulin secretion (IS) and IR are involved in GDM pathophysiology [1].”
BackgroundInfluentialMuscogiuri, G., Caporusso, M., Caruso, P., Poggi, C. D., Vitale, M., Zurru, A., Colao, A., & the Italian Study Group on Gender Difference in Endocrine Diseases (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02491-3 · Cited by 14
“…requires the β-cells adaptation to maintain glucose homeostasis: if the normal metabolic adaptations to pregnancy do not ade - quately occur, Gestational Diabetes Mellitus (GDM) can occur, with an higher risk of developing prediabetes and, subsequently, T2DM in the post-partum [ 76 ] (Table 3).”
Tsokkou, S., Tzintros, S.-T., Konstantinidis, I. K., Keramas, A., Georgaki, M.-N., Stamoula, Ε., & Matsas, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051646 · Cited by 14
“In GDM, however, the β -cells are unable to make up for the insulin resistance, which leads to hyperglycemia [17].”
InfluentialOikonomou, E., Chatzakis, C., Stavros, S., Potiris, A., Nikolettos, K., Sotiriou, S., Domali, E., Nikolettos, N., Sotiriadis, A., & Gerede, A. (2025) · Life · doi:10.3390/life15020210 · Cited by 11
“Gestational diabetes mellitus (GDM) is a significant public health concern with a pooled global standardized prevalence of 14.0% [1,2], indicating a burgeoning epidemic [3].”
InfluentialZhang, W., Zhao, X., & Li, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.657802 · Cited by 14
“The classical view is that placental hormones, prolactin, progesterone, and glucocorticoid antagonize the increased insulin level and insulin resistance during pregnancy is an important factor in the pathogenesis of GDM (8, 9).”
BackgroundLu, L., Ma, Y., Deng, J., Xie, J., & Huang, C. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s377041 · Cited by 9
“Previous studies have demonstrated that insulin resistance, chronic inflammation, obesity, genetic factors, oxidative stress, and defective insulin secretion contribute to the development of GDM.(1,29) However, the exact mechanisms underlying the pathogenesis of GDM are still largely unknown.”
BackgroundSalamanca-Sanabria, A., Liew, S. J., Mair, J. L., Iorio, M. D., Ling, Y. D. Y., Tint, M. T., Wei, Y. T., Lim, K. M. X., Ong, D., Chooi, Y. C., et al. (2024) · Trials · doi:10.1186/s13063-024-08247-x · Cited by 11
Spann, R. A., & Grayson, B. E. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00221-7 · Cited by 9
Jacobsen, K. H., Aalders, J., Mortensen, K. S. B., Andersen, M., Snogdal, L. S., Christensen, M. H., Vinter, C. A., Højlund, K., & Jensen, D. M. (2022) · Journal of Diabetes Research · doi:10.1155/2022/4900209 · Cited by 13
Grinberg, K., & Yisaschar-Mekuzas, Y. (2024) · Healthcare · doi:10.3390/healthcare12141438 · Cited by 16
“The American Diabetes Association classifies GDM as first-time diabetes detected during the second or third trimester of pregnancy, although its classification under type 1 or type 2 diabetes is not entirely clear [5].”
BackgroundRole of Insulin Resistance in Gestational Diabetes Mellitus: A Literature Review
Maqbool, M. (2022) · Chettinad Health City Medical Journal · doi:10.24321/2278.2044.202218 · Cited by 17
Sun, Y., Zhou, Y., Zhang, Y., Wang, H., Chi, Z., Chen, X., & Xu, D. (2022) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2022043275 · Cited by 10
Luo, P., Fan, Y., Xiong, Y., Feng, H., Yang, Z., Zhang, C., & Mei, B. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00963-1 · Cited by 13
“It is well known that GDM and T2DM share the same pathogenesis (insulin resistance and pancreatic β cell dysfunction) [21] and share a common genetic background [22].”
BackgroundVedika, R., Sharma, P., & Reddy, A. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01232-2 · Cited by 9
“The placenta functions as a barrier between foetal and maternal circulation, is therefore exposed to hyperglycemic environments and therefore the consequences of GDM. Transport of amino acids, glucose and lipids across the pla - centa is impaired due to GDM [ 27 ].”
BackgroundGuo, M., Fang, Y., Peng, M., He, C., Chen, J., Sun, B., Liu, C., Zhou, Y., Zhang, H., & Zhao, K. (2024) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2024.114419 · Cited by 12
Association of social jetlag with gestational diabetes: Qazvin Maternal and Neonatal Metabolic Study
Hashemipour, S., Lalooha, F., Ghorbani, A., Nozari, F. H., Badri, M., Abbaslou, M. A., Zohal, M. A., Abbasi, M., & Elmizadeh, K. (2022) · Chronobiology International · doi:10.1080/07420528.2022.2090372 · Cited by 10
“Pregnancy is a diabetogen situation mainly due a surge of placenta-produced counter-regulatory hormones that cause progressive insulin resistance (Plows et al. 2018).”
BackgroundJackson, K. E., Karasek, D. A., Gemmill, A., Collin, D. F., & Hamad, R. (2024) · Epidemiology · doi:10.1097/ede.0000000000001779 · Cited by 11
Yıldırım, S. B., Altuntaş, N. B., & Tekın, Y. B. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2371979 · Cited by 17
“GDM etiology has been commonly linked to the dysregulation of placental hormones, including alteration in progesterone and estrogen delivery that disrupts insulin sensitivity [12].”
Vito, M. D., Alameddine, S., Capannolo, G., Mappa, I., Gualtieri, P., Renzo, L. D., LORENZO, A. D., Antonio, F. D., & Rizzo, G. (2022) · Healthcare · doi:10.3390/healthcare10122490 · Cited by 17
Moringa oleifera decrease blood sugar level and blood pressure in pregnant diabetic rats
Gondo, H. K. (2021) · Journal Of Advanced Pharmacy Education And Research · doi:10.51847/fdgcclkxof · Cited by 9
“The pathophysiology of gestational diabetes is divided into two: 1) the role of the fetoplacental unit and 2) the role of adipose tissue [5].”
BackgroundLi, M., Huang, Y., Xi, H., Zhang, W., Xiang, Z., Wang, L., Li, X., & Guo, H. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0528 · Cited by 10
“It is a common complication of pregnancy, characterized by impacted glucose tolerance due to pancreatic beta cell dysfunction [2].”
BackgroundInsulin receptor cleavage induced by estrogen impairs insulin signaling
Yuasa, T., Takata, Y., Aki, N., Kunimi, K., Satoh, M., Nii, M., Izumi, Y., Otoda, T., Hashida, S., Osawa, H., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002467 · Cited by 11
Tranidou, A., Magriplis, E., Apostolopoulou, A., Tsakiridis, I. G., Chroni, V., Tsekitsidi, E., Kalaitzopoulou, I., Pazaras, N., Chourdakis, M., & Dagklis, T. (2024) · Nutrients · doi:10.3390/nu16091375 · Cited by 12
“This condition, exacerbated by factors such as genetic predisposition, hormonal changes in pregnancy that increase insulin resistance, and lifestyle factors including diet and physical activity, leads to varied severities of hyperglycemia [2].”
BackgroundSerum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?
Trocmé, C., Gonnet, N., Tommaso, M. D., Samouda, H., Cracowski, J., Cracowski, C., Lambert-Porcheron, S., Laville, M., Nobécourt, E., Gaddhab, C., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.596141 · Cited by 10
“This gestational diabetes often results in potentially severe complications either during pregnancy or at the parturition and even later on in life both for the infant and the mother (Chiefari et al., 2017; Casagrande et al., 2018a; Plows et al., 2018).”
BackgroundCommon pregnancy complications and polyphenols intake: an overview
Deckmann, I., Santos‐Terra, J., Martel, F., & Carletti, J. V. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2160960 · Cited by 10
“GDM is also a highly prevalent disease and affects around 7%–10% of the pregnancies (Behboudi-Gandevani et al. 2019), presenting important effects on the fetus, especially overweight and increased risk of cardiovascular alterations (which also applies to the mother) (Plows et al. 2018).”
BackgroundImaging Review of Obstetric Sequelae of Maternal Diabetes Mellitus
Aboughalia, H., Pathak, P., Basavalingu, D., Chapman, T., Revzin, M. V., Sienas, L., Deutsch, G. H., Katz, D. S., & Moshiri, M. (2021) · Radiographics · doi:10.1148/rg.210164 · Cited by 11
Assessment of the incidence of postpartum depression in the first week of confinement
Niegowska, K., & Kobos, E. (2019) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/114661 · Cited by 11
Ustianowski, P., Malinowski, D., Safranow, K., Dziedziejko, V., Tarnowski, M., & Pawlik, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020243 · Cited by 8
“A number of genetic factors are currently being considered that may cause a predisposition to GDM [2,3].”
BackgroundResultNiebrzydowska-Tatus, M., Pełech, A., Bień, K., Mekler, J., Santiago, M., Kimber-Trojnar, Ż., & Trojnar, M. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031829 · Cited by 9
“The increased metabolic demand of pregnancy causes blood glucose to rise and insulin sensitivity to fall, and pancreatic β -cells subsequently undergo hyperplasia and hypertrophy [3].”
BackgroundInfluentialLi, K., Li, H., Song, X., Kuang, X., Liu, S., Zhu, S., & Li, D. (2023) · Food & Function · doi:10.1039/d2fo03320h · Cited by 10
Li, L., Yang, K., Ye, F., Xu, Y., Cao, L., & Sheng, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9618 · Cited by 8
“Dysfunction of pancreatic β‐cells have been reported to be a central component in the pathogenesis and development of GDM (9,10).”
BackgroundWang, J., Wang, N., Guo, H., Niu, X., Hu, S., Pan, X., Wang, M., Zhang, D., Song, L., & Sun, B. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf178 · Cited by 8
Ahmad, R., Nnamdi, O. A., Etando, A., Sharma, P., Sinha, S., Chowdhury, K., Rowaiye, A. B., Akter, S., Mou, T. J., Dhingra, S., et al. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.142387 · Cited by 17
Steroid profiling and genetic variants in Chinese women with gestational diabetes mellitus
Yuan, T., & Li, Y. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105999 · Cited by 9
The Relationship Between Gestational Diabetes and the Risk of Cancer: A Systematic Review
Slouha, E., Gates, K. M., Al-Geizi, H., et al. (2024) · Cureus · doi:10.7759/cureus.53328 · Cited by 8
Yang, X. M., Song, Y., Zhang, J., Wang, Y., Huang, H., Zhang, J., & Gao, L. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s489118 · Cited by 9
“…Setting, and Participants miscarriage, or neonatal death; (f) history of delivering a large baby (birth weight ≥ 4000g); or (g) history of GDM. 38,39 Women were excluded if they had any contraindications to physical activity, including unexplained persistent vaginal bleeding; severe…”
Ali, U., Cure, L., Lewis, R. K., Rattani, A., Hill, T., & Woods, N. K. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03306-6 · Cited by 12
“Maternal obesity is a significant and strongly associated risk factor for GDM suggesting that nearly 50% of GDM cases could be prevented if women had a healthy BMI [3, 8–10].”
BackgroundPérez-López, F. R., López-Baena, M. T., Ulloque‐Badaracco, J. R., & Benites-Zapata, V. A. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01306-9 · Cited by 9
The Impact of Gestational Diabetes on Kidney Development: is There an Epigenetic Link?
Tortelote, G. G. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01569-9 · Cited by 12
“…offset the increased insulin resistance, leading to maternal glucose intolerance and the onset of GDM. Obesity exacerbates this process by inducing insulin resistance and hyperinsulinemia, which are thought to be driven by low-grade systemic inflammation and subclinical endotoxemia [6, 8, 22, 24].”
Karasek, D. A., Collin, D. F., Hamad, R., Jackson, K. E., & Gemmill, A. (2025) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.70000 · Cited by 10
“Increases in gestational hypertension and GDM following the stress of shelter- in-place support a potential stress and inflammatory pathway [48].”
PREVALÊNCIA DO DIABETES MELLITUS GESTACIONAL EM UM AMBULATÓRIO DE ALTO RISCO DO OESTE DO PARANÁ
Rossett, T. C., Wittmann, T., Rotta, K., et al. (2020) · FAG JOURNAL OF HEALTH (FJH) · doi:10.35984/fjh.v2i2.193 · Cited by 8
Hu, R., Zou, L., Wang, L., Xu, C., Qi, M., Yang, Z., Jiang, G., & Ji, L. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105300 · Cited by 10
Thakur, A., Agrawal, S., Chakole, S. V., & Wandile, B. V. (2023) · Cureus · doi:10.7759/cureus.51016 · Cited by 20
Myeloperoxidase G-463A and CYBA C242T genetic variants in gestational diabetes mellitus
Jiang, C., Zhou, M., Bai, H., Chen, M., Yang, C., Hu, K., Wu, Y., Liu, Q., Zhao, Y., Liu, X., et al. (2023) · Endocrine Connections · doi:10.1530/ec-22-0369 · Cited by 10
Lefta, R. M., Hjazi, A. M., Skakodub, A. A., Dham, A., Sapaev, I. B., Khlewee, I. H., Alawadi, A. H., Alsaalamy, A. H., Habash, R. T., & Najafi, M. L. (2024) · Environmental Sciences Europe · doi:10.1186/s12302-024-00878-w · Cited by 10
Lantzanaki, M., Veneti, S., Mintziori, G., Begou, O., Pappas, P. D., Gika, H., Goulis, D. G., Bili, H., Taousani, E., & Vavilis, D. (2022) · Metabolites · doi:10.3390/metabo12111123 · Cited by 8
“These results are not the expected ones based on our initial hypothesis about the similar mechanisms of T2DM and GDM and elevated ceramides as biomarkers in patients with T2DM.”
BackgroundInfluentialAssociation of gut microbiota with overweight/obesity combined with gestational diabetes mellitus
Mei, S., Chen, Y.-S., Long, Y., Cen, X., Zhao, X., Zhang, X., Ye, J., Gao, X., & Zhu, C. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002010 · Cited by 13
“The proposed aetiological mechanisms of obesity/overweight leading to GDM include inflammation, oxidative stress, insulin resistance and imbalance of gut microbiome [6].”
Qi, S., & Dong, Y. (2022) · Disease Markers · doi:10.1155/2022/7285639 · Cited by 12
“It is predicted that 50% of GDM patients will develop diabetes in 22-28 years after pregnancy, resulting in a heavy economic and medical burden to society and family [4, 5].”
BackgroundLv, X., & An, Y. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303275367240103102801 · Cited by 11
Tığlı, A., Baykuş, Y., Deniz, R., Selçuk, K. T., Şener, N., Değirmenci, Y. E., Akıncı, G. E., Acarturk, İ. Z., Sertdemir, N., & Aydın, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1765602 · Cited by 13
“Advanced maternal age and increased BMI are well-established risk factors for GDM as they contribute to insulin resistance and impaired β -cell function (40).”
Giommi, C., Lombó, M., Montik, N., Paolucci, M., Notarstefano, V., Carpini, G. D., Ciavattini, A., Ragusa, A., Maradonna, F., Giorgini, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032240 · Cited by 10
“The consequences derived from GDM for the fetus are a higher risk of macrosomia, icterus, glycemic disorders, and obesity [5,6].”
BackgroundSerum Vaspin Levels in Gestational Diabetes Mellitus: A Meta-Analysis
Zhou, B., Liu, Y., Ren, Y., Yan, X., Fan, J., Tang, L., & Wen, M. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0089 · Cited by 8
Lipids, apolipoproteins and gestational diabetes mellitus: a Mendelian randomization study
Shan, D., Wang, A., & Yi, K. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06556-2 · Cited by 9
“Environmental factors, lifestyle choices, and genetics all have a role in the pathophysiology of GDM [12, 13].”
BackgroundGrigoryan, O. R., Михеев, Р. К., Kurinova, A. N., Чернова, М. О., Sazonova, D. V., Ахматова, Р. Р., Ibragimova, L. I., Absatarova, Y. S., Sheremetyeva, E. V., Ивановна, Д. Е., et al. (2021) · Problems of Endocrinology · doi:10.14341/probl12756 · Cited by 14
Bakiris, E., Luiro, K., Jokelainen, J. J., Morin-Papunen, L. C., Keinanen-Kiukaanniemi, S. M., Kaikkonen, K., Piltonen, T., Tapanainen, J. S., & AUVINEN, J. P. (2024) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14861 · Cited by 14
Shetty, N. P., Shetty, J., Hegde, V., Dharne, S. D., & Kv, M. (2024) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2024.101051 · Cited by 15
Sun, Y., Zhu, B., Meng, X., Yin, B., Wu, K., Liu, Y., Zou, D., Xue, J., Sun, X., Zhang, D., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.999154 · Cited by 8
“A number of interrelated factors including overweight/obesity and steroids affecting both insulin secretion and insulin resistance are involved in the pathophysiology of GDM (10).”
BackgroundThe Impact of Excessive Gestational Weight Gain on Adverse Perinatal Outcomes: A Systematic Review
Kalli, E., Potiris, A., Domali, E., Zikopoulos, A., Kathopoulis, N., Drakaki, Ε., Machairiotis, N., Louis, K., Gkirgkinoudis, A., Christodoulaki, C., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041197 · Cited by 13
“Some of the most common perinatal complications are gestational diabetes mellitus which complicates almost 14% of all pregnancies worldwide [5], preterm birth ( 37 weeks of gestation) which refers to 4–16% of neonates born in 2020, gestational hypertensive disorders (gestational hypertension,…”
Cellular and molecular overview of gestational diabetes mellitus: Is it predictable and preventable?
Lim, P.-Q., Lai, Y.-J., Ling, P., & Chen, K.-H. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i11.1693 · Cited by 15
Adverse pregnancy outcomes and risk of type 2 diabetes in postmenopausal women
Zhu, K., Wactawski‐Wende, J., Mendola, P., Parikh, N. I., LaMonte, M. J., Barnabei, V. M., Blair, R. H., Manson, J. E., Liu, S., Wang, M., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.07.030 · Cited by 10
Sawangpanyangkura, T., Laohapand, P., Boriboonhirunsarn, D., Boriboonhirunsarn, C., Bunpeng, N., & Tansriratanawong, K. (2021) · Journal of Dental Sciences · doi:10.1016/j.jds.2021.09.024 · Cited by 8
“This result suggested that overexpression of miR-223 mainly contributed to periodontitis and was possibly modified by GDM. GCB might be a novel source of biomarkers for further studies to identify other miRNAs related to GDM and periodontitis.”
BackgroundInfluentialAlwash, S. M., McIntyre, D. H., & Mamun, A. A. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2195524 · Cited by 12
“related to glucose regulation, which may lead to GDM, are present before pregnancy and are not simply induced by pregnancy in women who develop GDM [37].”
BackgroundIrisin as an emerging target in the regulation of reproductive functions in health and disease
Nalla, S. V., Jayapradha, P., Lalruatmawii, Nandheeswari, K., Naxine, P., Vigneshwaran, G., Rohilla, G., Dubey, I., & Kushwaha, S. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114529 · Cited by 12
Chen, B., Chen, X., Li, J., Hu, R., Yang, L., Li, H., Liu, X., Cannon, R. D., Saffery, R., Novakovic, B., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116505 · Cited by 13
Role of macrophages reprogramming in pathogenesis of gestational diabetes mellitus
Milan, K. L., Shree, R. A., Nandana, N., Leela, R., & Ramkumar, K. M. (2025) · Cytokine · doi:10.1016/j.cyto.2025.157041 · Cited by 8
Impact of Adverse Gestational Milieu on Maternal Cardiovascular Health
Alkhatib, B., Salimi, S., Jabari, M., Padmanabhan, V., & Vyas, A. K. (2023) · Endocrinology · doi:10.1210/endocr/bqad060 · Cited by 8
Novel first-trimester serum biomarkers for early prediction of gestational diabetes mellitus
Tian, S., Liu, M., Han, S., Wu, H., Qin, R., Ma, K., Liu, L., Zhao, H., & Li, Y. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00372-z · Cited by 12
“In addition to in fl ammatory factors, adipocytokines such as leptin and adiponectin have been implicated in the in fl ammatory processes associated with GDM development, in fl uencing glucose metabolism and insulin sensitivity [12, 22, 23].”
Teni, M. T., Loux, T. M., & Kuhlmann, A. S. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2139175 · Cited by 8
Zhang, X., Yang, N., Wang, M., Ge, J., Zhu, H., He, J., & Ge, W. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115044 · Cited by 9
Glucagon delivery – An overview of current and future devices
Рабинович, А. Л., & Priefer, R. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.028 · Cited by 8
Dube, R., Bambani, T., Saif, S., Hashmi, N., Patni, M. A., & Kedia, N. R. (2024) · Diabetology · doi:10.3390/diabetology5040032 · Cited by 14
“The physiological changes in pregnancy to ensure an adequate supply of glucose for the fetus predispose women to develop GDM [94,98].”
He, Y., Zhu, W., Qiu, Y., & Zhou, K. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07217-8 · Cited by 10
Yasuda, S., Inoue, K., Iida, S., Oikawa, Y., Namba, A., Isshiki, M., Inoue, I., Kamei, Y., Shimada, A., & Noda, M. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107850 · Cited by 8
Metabolic Characteristics of Gestational Diabetes Mellitus and the Effects on Pregnancy Outcomes
Luo, P., Fan, Y., Xiong, Y., Zhang, C., Yang, Z., Sun, F., & Mei, B. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s390999 · Cited by 9
Akinjiyan, M. O., Atiba, A. S., & Asaolu, M. F. (2025) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-024-00206-4 · Cited by 9
“This finding is similar to that of Ploughs et al., who reported that GDM could be a function of heredity [23].”
Huang, X., & Guo, L. (2023) · Molecular Reproduction and Development · doi:10.1002/mrd.23667 · Cited by 10
“Women with GDM are at higher risks of abortion, maternal cardiovascular disease, type 2 diabetes, and macrosomia and birth complications in the infant (Plows et al., 2018).”
BackgroundPan, Y., Gu, R., Wang, J., Li, Q., Zhang, Y., Xu, Y., Ji, S., Wu, J., & Wei, L. S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112949 · Cited by 11
Ahmad, F., Uzair, S. A., Lakshmanan, A. P., Alabduljabbar, S., Ahmed, S. H., Kabeer, B. S. A., Marr, A. K., Kino, T., Brummaier, T., McGready, R. M., et al. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70058 · Cited by 8
Feng, Y., Feng, Q., Yin, S., Xu, X., Song, X., Qu, H., & Hu, J. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1707797 · Cited by 7
Simbar, M., Mokhlesi, S., Tehrani, F. R., et al. (2023) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/ijnmr.ijnmr_474_21 · Cited by 7
“[1] GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually.[2] In one meta‐analysis in Iran, the overall prevalence of GDM in 2015 was estimated at about 3.”
BackgroundAyele, A. D., Gedefaw, G. A., Alemu, B. K., Wang, Y., & wang, C. C. (2025) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2025-114065 · Cited by 13
Zhang, X., & Jin, Y. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111263 · Cited by 9
Gestational diabetes mellitus in women born small or preterm: Systematic review and meta-analysis
Tsujimoto, Y., Kataoka, Y., Banno, M., Taito, S., Kokubo, M., Masuzawa, Y., & Yamamoto, Y. (2021) · Endocrine · doi:10.1007/s12020-021-02926-4 · Cited by 8
“The underlying mechanism of the association between preterm birth or SGA status and subsequent GDM may be gestational malnutrition due to maternal malnutrition or placental insufficiency [44].”
BackgroundYang, X., Yang, C., Lü, W., & Yang, X. (2022) · Pharmacognosy Magazine · doi:10.1177/09731296221137440 · Cited by 8
Caputo, M., Bullara, V., Mele, C., Sama, M., Zavattaro, M., Ferrero, A., Daffara, T., Leone, I., Giachetti, G., Antoniotti, V., et al. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9474805 · Cited by 11
Xu, P., Sun, Z., Zheng, S., Pan, L., Dong, S., Jin, H., Chen, P., & Shu, C. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123207 · Cited by 7
From body mass index to body composition in female infertility
Darıcı, E., Pais, F., Leemans, L., Strypstein, L., Tournaye, H. J., Vos, M. D., Waele, E. D., & Blockeel, C. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104941 · Cited by 14
Triantafyllidou, P., Papadopoulou, A., Thymara, E., Papaevangelou, V., Mastorakos, G. P., Papadimitriou, A., Kalantaridou, S., Stratakis, C. A., & Alexopoulou, E. (2023) · Current Vascular Pharmacology · doi:10.2174/1570161121666230727150854 · Cited by 8
Dawid, M., Pich, K., Mlyczyńska, E., Respekta, N., Wachowska, D., Greggio, A., Szkraba, O., Kurowska, P., & Rak, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.006 · Cited by 8
ZJU index as a predictive biomarker of gestational diabetes mellitus: a prospective cohort analysis
Xu, Z., Li, X., Wang, H., Xu, L., & Li, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1570771 · Cited by 9
Sun, H., Jiao, J., Ren, Y., Guo, Y., & Wang, Y. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23233 · Cited by 7
“Despite the fact that many research have looked into the placental pathology of gestational diabetes mellitus (GDM), 7,15 the pathophysiology is still unknown, limiting the development of effective and promising treat-ment targets.”
BackgroundYang, X. M., Xiang, Z., Zhang, J., Song, Y., Guo, E., Zhang, R., Chen, X., Chen, L., & Gao, L. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05995-7 · Cited by 15
“…BMI ≥ 24 kg/m 2 , family history of type 2 diabetes, polycystic ovary syndrome, previous macrosomia, previous GDM, previous glucose intolerance, previous fetal anomaly or hydration, current pregnancy with fetus growing than the gestational age, hydration, or repeated colitis) [65, 66].”
BackgroundWei, J., Dong, T., Chen, M., Luo, X. M., & Mi, Y. (2024) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000240 · Cited by 12
Yong, H. Y., Shariff, Z. M., Yusof, B. N. M., Rejali, Z., Tee, Y. Y. S., BINDELS, J. G., & van der Beek, E. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272253 · Cited by 8
“As women are already in a mild state of insulin resistance during early pregnancy, the excessive GWG in addition to higher pre-pregnancy BMI of women with short stature may further enhance beta cell dysfunction and increase the risk of GDM [40].”
Background
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.